CORC

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: Pharmacokinetics, toxicity, and preliminary efficacy. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Shi, Yuankai;  Yang, Jianliang;  Gui, Lin;  Liu, Peng;  Han, Xiaohong
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population 会议论文
作者:  Ye, D.;  Sun, Y. H.;  Wei, Q.;  Yao, X.;  Ye, Z. Q.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/19
Docetaxel plus Prednisone versus Mitoxantrone plus Prednisone as First-Line Chemotherapy for Metastatic Castration-Refractory Prostate Cancer: Long-Term Effects and Safety in Chinese Patients 会议论文
作者:  Shen, Y.;  Bian, X.;  Xie, H.;  Zhu, Y.;  Dai, B.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
PEGylated liposomes modified with LHRH analogs for tumor targeting 会议论文
JOURNAL OF CONTROLLED RELEASE, 2011-11-30
作者:  He, Yingna;  Zhang, Linhua;  Song, Cunxian
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/13
Clinical study of fludarabine, mitoxantrone, and dexamethasone in the treatment of refractory or relapsed multiple myeloma. (CPCI-S收录) 会议论文
BLOOD
作者:  Luo, SK;  Li, J;  Hong, WD;  Zhao, Y;  Tong, XZ
收藏  |  浏览/下载:1/0  |  提交时间:2019/04/18


©版权所有 ©2017 CSpace - Powered by CSpace